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Quinone-Based Fluorophores for Imaging Biological Processes 
Gleiston G. Dias,a Aaron King,b Fabio de Moliner,b Marc Vendrellb* and Eufrânio N. da Silva 
Júniora* 
Quinones are privileged chemical structures playing crucial roles as redox and alkylating agents in a wide range of 
processes in cells. The broad functional array of quinones has prompted the development of new chemical approaches, 
including C-H bond activation and asymmetric reactions, to generate probes for examining their activity by means of 
fluorescence imaging. This tutorial review covers recent advances in the design, synthesis and applications of quinone-
based fluorescent agents for visualizing specific processes in multiple biological systems, from cells to tissues and complex 
in vivo organisms. 
 
1. Introduction  
Quinones and their derivatives have been studied for over a century 
due to their electronic and chemical properties. In particular, 
quinones present several unique features associated with their 
redox potential, which allow them to undergo both one- and two-
electron reductions and form semiquinones and hydroquinones, 
respectively. Their reactivity and pharmacological properties can be 
also tuned through different structural modifications, which have 
been described in many publications. However, although the 
earliest reports dealing with the chemistry of quinones date back to 
the late 19th century, it was not until the 1950s that their 
abundance amongst biomolecules started to be understood. A 
milestone in this research area was the discovery in 1957 of 
coenzyme Q, which was found to be ubiquitous in animals and 
many bacteria -and so-called ubiquinone- and to play an essential 
role in mitochondrial electron transport.1 Ever since, naturally 
occurring quinones have been subsequently found to be involved in 
multiple biological contexts, ranging from bone formation in 
mammals to self-defense mechanisms in insects. 
A wide array of molecules containing quinone moieties show 
remarkable pharmacological activity. For instance, the plant-
derived naphthoquinone plumbagin has been found to induce cell 
death in human cervical cancer cells.2 Perhaps more notably, 
atovaquone (Mepron) is a commercially available medication for 
the treatment of pneumocystis pneumonia, toxoplasmosis and 
malaria. Besides, the redox properties of quinones can be 
advantageously exploited for the preparation of prodrugs. In fact, 
their conjugation to known therapeutic agents can render drugs in 
an inactive yet bioavailable form so that they are activated in vivo in 
cells undergoing reductive metabolism. Using this concept, novel 
benzoquinone derivatives of the anti-angiogenic compounds 
biochanin A and semaxanib have been synthesized and evaluated as 
potential prodrug systems.3 In these molecules, it has been shown 
that the reduction of the benzoquinone unit leads to the release of 
active drugs in targeted tissues.  
Another field in which quinones are being investigated is the 
development of probes for sensing processes in biological systems, 
ranging from cells to whole intact organisms. Quinones have shown 
excellent performance in combination with gold nanoparticles for 
the sensing of redox potentials in biological environments by means 
of surface-enhanced Raman spectroscopy (SERS). For instance, the 
functionalisation of gold nanoshells with naphthoquinone 
derivatives has been described as a useful approach to monitor 
redox potentials in real time.4 Another family of widely used 
analytical tools regards the design and assembly of fluorescent 
probes. Fluorescence-based assays have consolidated as a highly 
sensitive methodology for interrogating non-invasively cellular 
events, including the localisation and dynamics of gene expression, 
Key learning points 
1. Recent advances in chemical strategies to synthesize small reactive fluorophores containing quinoidal moieties. 
2. Reactivity of quinone-based fluorophores as activatable probes for the detection of multiple biomarkers. 
3. Trimethyl lock quinones as privileged scaffolds to monitor enzymatic processes in biological systems. 
4. The fluorescence derivatisation of quinones with therapeutic action to study their mechanism of action and to monitor drug release.  
5. Perspectives and challenges of quinone-based chemical probes in biological imaging. 
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protein expression, and molecular interactions in living cells and 
tissues. Combinations of fluorescent probes also allow us to 
sensitively detect multiple biological molecules when suitable 
optical filters are used. In addition to being low-cost, safe, and 
displaying long shelf-lives, small molecule fluorophores can produce 
images at molecular resolution with excellent sensitivity. One of the 
main challenges currently being pursued in this research area is the 
synthesis of activatable fluorescent probes, which emit 
fluorescence upon activation via interaction with a specific analyte, 
or by a change in the surrounding microenvironment. These 
activatable fluorophores have been reported for numerous 
different applications.5 Driven by the continued interest in the 
preparation of such sophisticated probes, considerable advances in 
overcoming the inherent difficulties in their synthesis have been 
attained. Such achievements have been possible with the design of 
novel and effective synthetic strategies that had been traditionally 
limited to medicinal chemistry research programmes,6,7 such as 
multicomponent reactions, C-H activation processes and 
cycloadditions, among others.8 
While the chemistry of quinones and most aspects related to their 
synthesis, properties and usage have been surveyed in several 
review articles over the last decade, to date there were no reports 
covering the integration of quinones within fluorescent probes and 
their application for bioimaging studies. This tutorial review aims to 
summarize the growing number of innovative techniques relying 
upon the unique electronic and chemical properties of quinone 
derivatives for biological imaging and theranostic purposes. 
2. Activatable fluorescent probes based on 
quinoidal systems 
The unique chemistry of the quinone scaffold makes it an excellent 
building block for the synthesis of activatable fluorescent probes. 
Smart quinoidal probes only fluorescing upon recognition of target 
analytes have been described using different activation 
mechanisms. Such structures typically consist of a fluorophore, 
which acts as the reporter, linked to a quenching quinone, which 
undergoes a chemical transformation upon activation. This 
transformation typically abates its quenching activity and thus 
results in an increased fluorescence emission. In particular, 
photoinduced electron transfer (PeT) plays a pivotal role in the 
activation of these fluorophores. PeT is an excited state electron 
transfer process in which an electron is transferred from a donor 
orbital to an acceptor orbital, typically leading to a quenching 
effect.9 The PeT mechanism has been widely exploited to produce 
molecules that, upon binding to the analyte, present a donor orbital 
with lower energy to reduce the electron transfer and increase the 
fluorescence emission. In this section, examples in which quinones 
have been an essential part of such activatable fluorescent probes 
for a range of biomarkers will be surveyed. 
 
Biothiols such as cysteine, homocysteine, and glutathione (GSH) are 
present in nearly all cells and play a critical role as mediators in 
different cellular processes. In particular, they are key components 
of the endogenous antioxidant system that maintains the  
intracellular redox potential. For example, GSH prevents cellular 
damage from free radicals as well as heavy metals. Abnormal levels 
of GSH have been found in patients with Alzheimer’s disease and 
different cardiovascular conditions. As a result, highly sensitive 
tools for the in situ detection of thiols in cells have important 
applications in biological and biomedical research.  
 
Quinones are well suited for the imaging of biothiols as they are 
excellent Michael acceptors, and therefore prone to nucleophilic 
attack by thiol groups. Since this nucleophilic reaction can occur in 
biological conditions, it represents an ideal activation strategy for 
the design of activatable probes for the detection of biothiols in 
vivo. The first example of quinone-fluorescent reporters for 
biothiols was reported by Huang et al., who successfully synthesized 
a red fluorescent probe (λem.: 595 nm) consisting of a trimethyl 
benzoquinone moiety directly linked to a red-shifted coumarin 
scaffold through an ether moiety.10 Advantageously, these 
fluorophores possessed remarkably long Stokes shifts (i.e., around 
90 nm), with minimal overlapping between absorbance and 
emission spectra and higher signal-to-background ratios. In this 
case, the coumarin core acted as the reporter upon activation of 
the probe, displaying strong fluorescence emission in the low 
energy region of the spectrum, thus minimizing background 
interference from biological samples. Notably, the fluorescence 
‘turn-on’ effect was triggered by a tandem reaction, where the 
initial reduction of the quinone moiety by thiol addition was 
followed by a quinone-methide rearrangement that released the 
fluorogenic coumarin core. This mechanism was further confirmed 
spectroscopically by the linear relationship between fluorescence 
intensity and thiol concentration, and competitive inhibition with N-
ethylmaleimide. Importantly, the probe was shown to be insensitive 
to various non-thiol amino acids and other biological reductants.  
 
Subsequently, the same concept was demonstrated in vitro by Chi 
et al., by means of a tetraphenylethylene-based fluorophore linked 
to a benzoquinone.11 Using a slightly different chemical design, the 
reporter was directly connected to the reactive site and the 
fluorophore was not released upon reaction with the analytes. 
Instead, the activation of the probe proceeded through a thiol-ene 
click reaction, which led to the reduction of the quinone structure 
towards the hydroquinoidal form. Remarkably, good selectivity for 
thiol-containing amino acids and rapid response times (i.e., shorter 
than 1 min) were achieved. These properties enabled the use of the 
probe for in vitro imaging of murine nerve cells by confocal 
fluorescence microscopy. In those experiments, the probe was 
found to be cell-permeable and displayed strong blue fluorescence 
emission upon reaction with intracellular biothiols, without being 
activated by other amino acids lacking free thiol groups.  
 
Although selective and effective in different biological 
environments, the above mentioned probes displayed limits of 
detection in the low µM range, which might not be optimal for their 
in vivo application. The first quinone-based fluorescent probe 
capable of detecting submicromolar levels of biothiols was 
prepared by McCarley et al.12 The compound contained a reactive 
trimethyl benzoquinone and a napthalimide reporter (λem.: 540 nm), 
and was shown to detect low concentrations (i.e., in the nM range) 
of GSH, Cys and Hcy under physiological conditions and with a rapid 
response (i.e., around 5 min). Similarly to the above mentioned 
coumarin-based probe, the quinoidal moiety was eliminated upon 
reduction, leading to the release of the free fluorophore. The main 
advantages of this probe (e.g. rapid and selective reaction with 
biothiols, low limit of detection) were demonstrated by performing 
imaging experiments in human cells. High-magnification images of 
human H596 lung cancer cells were acquired and compared to 
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those incubated with the thiol scavenger N-ethylmaleimide, 
corroborating the selective activation mechanism. 
 
Another challenge in the field of biothiol sensing is the selective 
detection of single thiol-containing analytes in the complex cellular 
environment. In this regard, Zhao et al. synthesized coumarin-
quinone probes (1) with high selectivity for GSH over other 
biothiols.13 The diethylamino-containing coumarin fluorophore 
(λem.: 485 nm) was directly linked to a benzoquinone unit, which 
underwent reduction upon GSH addition to block its quenching 
ability (Figure 1A). Selectivity was first attributed to the 
intramolecular cyclisation of the cysteine amino group of GSH onto 
a carbonyl group on the GSH-probe adduct to afford a six-
membered thiazine heterocycle, the formation of which was 
confirmed by mass spectral analysis. However, at physiologically 
relevant temperatures (i.e., 37 °C) the intermediate tautomerised 
to the phenol form as the thermodynamically stable product, being 
equally responsive to both GSH and Cys. Therefore, the ability to 
discriminate between the two analytes was the result of a 
discrepancy in the molecular energies of the two different adducts. 
The probe demonstrated excellent response times (i.e., shorter 
than 1 min) with a limit of detection in the submicromolar range. 
The authors also demonstrated the applicability of the probe for 
live cell imaging by confirming marginal cytotoxicity and acquiring 
fluorescence confocal microscope images in human HeLa cells.  
These examples highlight the broad applicability of the 
benzoquinone structure as a reactive moiety for the development 
of fluorescent probes for imaging biothiols. Overall, benzoquinone 
adducts display quick response times, high sensitivity and 
selectivity, as well as good permeability for cell imaging 
applications. 
 
Alongside the recognition of biothiols, quinone-based fluorophores 
have been also constructed for the detection of the nicotinamide 
adenine dinucleotide derivatives, such as NADH and NADPH, which 
play key roles in cellular metabolism as electron carriers. NADH is 
generated by the tricarboxylic acid cycle in a ratio of three 
molecules per cycle, while NADPH is the phosphorylated form 
involved in photosynthesis and glycolysis. In addition to their 
important physiological function, these dinucleotides have been 
also investigated as potential therapeutic agents for the treatment 
of neurodegenerative diseases. Upon activation, NAD(P)H act as 
reducing agents. Consequently, quinone activatable fluorescent 
probes have been designed by exploiting the reduction of quinone 
moieties for their detection in biological environments. Unlike the 
above described thiol-sensitive probes, these probes displayed a 
decrease in their emission upon NAD(P)H recognition and 
generation of the hydroquinones, since these attenuate the 
fluorescence via photoinduced electron transfer (PeT). One 
remarkable example was reported by Komatsu et al. with a rhodol 
fluorophore (λem.: 520 nm) conjugated to a reactive ubiquinone.14 
Since NAD(P)H requires the presence of a promoter to work as a 
reducing agent, the [(η5-C5Me5)Ir(phen)(H2O)]2+ Ir complex was 
used to allow the activation of NAD(P)H. The ubiquinone-rhodol 
fluorescent probe UQ-Rh (2) responded to intracellular NAD(P)H 
with around 9-fold decrease in fluorescence intensity in the 
presence of the Ir promoter (Figure 1B). NAD(P)H activation was 
imaged in situ in HeLa cells following addition of the Ir complex, 
after which the fluorescence intensity rapidly decreased. This work 
represents an interesting example of quinone-based probes for 
analysing the concentration of NAD(P)H in cells and its implications 
in tissue homeostasis. 
 
Most cellular functions rely on the continuous and adequate supply 
of oxygen from blood vessels. A steady oxygen level is preserved in 
normal tissues by the so-called oxygen homeostasis, whose 
alteration can lead to hypoxia. Hypoxic cells are characteristic by 
having a deficiency in oxygen supply and relevant in multiple 
diseases, including malignant solid tumours, inflammatory diseases 
and ischemia. In particular, hypoxic tumours have been found to 
show enhanced resistance to conventional therapeutic approaches 
and their targeting constitutes a highly unmet clinical need. As a 
result, there has been an increasing demand for hypoxia-specific 
fluorescent probes that can activate specifically in those 
environments. Notably, indolequinones can undergo one-electron 
reductive elimination under hypoxic conditions. Given the ability of 
quinones to quench fluorescence emission, the combination of 
indolequinones and fluorophores has been exploited to generate 
fluorescent probes to detect and visualize hypoxic 
microenvironments. This application was first described by 
Nishimoto et al., who conjugated an indolequinone to two 
coumarin chromophores via 2,6-bis(hydroxymethyl)-p-cresol 
linkers.15 The resulting IQ-Cou (3) probe showed weak fluorescence 
due to efficient quenching by the indolequinone via intramolecular 
PeT. However, upon reduction of the indolequinone in hypoxic 
conditions, the coumarin unit was released from the quencher and 
an intense fluorescence ‘turn-on’ effect at 420 nm was observed 
(Figure 1C). The one-electron reduction of IQ-Cou (3) was shown to 
be suppressed by molecular oxygen in aerobic conditions, resulting 
in weak fluorescence emission. On the other hand, 4-fold 
fluorescence emission enhancement was observed in hypoxic 
conditions in vitro using HT-1080 human fibrosarcoma cells. In 
these experiments, the authors demonstrated that IQ-Cou (3) could 
be activated by intracellular reductase enzymes, representing a 
promising candidate for imaging hypoxia-specific biological 
environments. However, limitations of IQ-Cou (3) such as poor 
solubility in water and short absorption and emission wavelengths 
(380 nm and 420 nm, respectively) hinder the use for in vivo 
imaging applications. Improvements over these drawbacks were 
achieved by the groups of Tanabe and Nishimoto, who developed 
an alternative indolequinone probe utilising rhodol as the 
fluorophore.16 In fact, rhodol displays good water solubility as well 
as longer excitation wavelengths (i.e., around 550 nm) and 
relatively high fluorescence quantum yields. The rhodol-based 
probe IQ-R was used in A549 human lung adenocarcinoma cells, 
which are known to express high levels of NAD(P)H cytochrome 
P450 reductase. Cells were incubated with IQ-R under both hypoxic 
and aerobic conditions. While hypoxic cells displayed a bright 
fluorescence readout upon treatment with the probe, cells 
incubated in aerobic conditions displayed only minimal changes in 
fluorescence over the background. This distinctively different 
behaviour allowed them to distinguish between these two closely-
related cell populations, being the first example of hypoxic cell 
imaging by means of a quinone-derived activatable fluorophore.  
 
The variety of analytes that can be detected by using quinone-
based fluorophores demonstrates their versatility, which extends 
beyond the biomarkers and fluorophores described in this section. 
In fact, in addition to numerous small fluorescent molecules, 
quinones have been also successfully incorporated to 
semiconductor quantum dots (QDs) to generate bright and 
photostable fluorescent agents. QDs are small semiconductor 
particles with excellent potential for optical imaging due to their 
unique photophysical properties. In particular, QDs exhibit narrow 
Tutorial Review Chem Soc Rev 
This journal is © The Royal Society of Chemistry 2017 Chem. Soc. Rev., 2017, 00, 1-3 | 4 
Please do not adjust margins 
Please do not adjust margins 
and tunable emission profiles as well as excellent photostability and 
brightness. One important example is represented by ubiquinone-
QD bioconjugates for in vitro detection of the intracellular complex 
I, an enzyme whose impaired activity has been associated with the 
progression of Parkinson’s disease.17 In this example, ubiquinones 
were endowed with disulphide groups and conjugated to CdSe/ZnS 
QDs to afford molecular probes for imaging complex I in human 
neuroblastoma SH-SY5Y cells. Upon reduction of the terminal 
ubiquinone moiety by the NAD(P)H:complex I, the quenching 
ubiquinone was ‘switched off’ and an enhanced fluorescence signal 
was detected. The application of quinone-functionalised QDs for 
the detection of specific enzymes has been also demonstrated by 
Wu et al.,18 who investigated the NAD(P)H:quinone oxidoreductase 
isozyme 1 (NQO1). As detailed in the following section, NQO1 is a 
critical enzyme in cancer progression, being overexpressed in 
several types of cancer cells. QD probes containing Mn:ZnS 
reporters and trimethylquinone-propionic acids as reactive sites 
were prepared. The activation mechanism of these conjugates 
relied on an intramolecular cyclisation reaction facilitated by the 
reduction of the trimethylquinone core, which led to the activation 
of the QDs and the observation of increased fluorescence emission 
in human A549 cells.  
 
Figure 1. (A) Proposed fluorescence activation mechanism for the coumarin-benzoquinone probe (1) upon reaction with GSH. Confocal 
microscope fluorescence images of HeLa cells upon incubation with increasing concentrations of the probe and for different incubation 
times. (B) The ubiquinone-rhodol UQ-Rh (2) and its reactivity for NAD(P)H, leading to a ‘turn-off’ decrease in fluorescence emission. 
Confocal microscope fluorescence images of HeLa collected over the time-course of 4 minutes, where a 9-fold decrease in fluorescence 
intensity is observed upon deactivation of the rhodol fluorophore. (C) Simplified activation mechanism of the indolequinone-coumarin 
probe IQ-Cou in hypoxic conditions, resulting in the release of a fluorescent coumarin scaffold. Fluorescence spectra of IQ-Cou (3) upon X-
ray irradiation in hypoxic (left) and aerobic (right) conditions. Images reproduced with permission from Elsevier (ref. 13), and Wiley-VCH 
(ref. 14 and ref. 15).  
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3. Trimethyl lock quinones to monitor enzymatic 
processes 
Taming the reactivity of quinone-based chemical probes within 
biological systems is a remarkable challenge due to the complexity 
of the intracellular environment. Chemical control over the 
reactivity of biomolecules in a temporal and spatial manner can be 
attained with the ‘trimethyl lock system’, an o-
hydroxydihydrocinnamic acid derivative that undergoes rapid 
lactonization under physiological conditions to yield a 
dihydrocoumarin derivative. Its name arises from the three 
interlocking methyl groups that are responsible for its fast reaction 
rate. The lactonization can be triggered by enzymatic, chemical or 
photolytic processes. This key reactivity was first identified by 
Cohen et al. and it is the hallmark of this family of compounds.19 
 
Nowadays, the use of the trimethyl lock system represents an 
efficient and elegant chemical strategy to trigger the release of 
fluorescent compounds in well-defined biological environments and 
to enable the monitoring of specific intracellular events. As 
previously described, quinones have also the ability to quench 
fluorescence emission, and fluorescent trimethyl lock quinone-
based probes have been developed to exploit this property for 
optical imaging. Despite the complexity of the biological 
mechanisms involved in the activation of these molecules, the 
simple underlying concept is the release of a fluorescent species 
from a non-fluorescent precursor after enzyme activation, such as 
NQO1 (Figure 2A). 
 
NQO1, also known as DT diaphorase, is a detoxifying enzyme 
present in low levels in most healthy tissues, but it is often over-
expressed after exposure to quinones producing reactive oxygen 
species (e.g., quinones found in some foods, pollutants and 
cigarette smoke). NQO1 expression in normal cells after exposure 
to specific quinones is increased by c-fos/AP1, c-jun and the NF-E2-
related factor 2 (NRF2) transcription factors, which regulate the 
NQO1 gene at its hARE (human Antioxidant Response Element). 
NQO1 is over-expressed in many human solid cancers, including 
prostate, breast, colon, pancreatic and head and neck cancers. 
Whereas the mechanisms behind NQO1 over-expression in cancer 
formation, growth and metastasis have not been entirely 
elucidated, there is evidence that NQO1 stabilizes the protein p53, 
increases the efficacy of hypoxia-inducible factor 1 alpha (HIF1-a), 
and increases the metastatic capacity of cancer cells.20 Studies in 
melanoma cells also suggest that NQO1 oxidoreductase could 
protect cancer cells from oxidative stress and promote their 
proliferation by increasing expression of cyclins A2, B1 and D1. 
Moreover, NQO1 can enhance the activity of hypoxia-inducible 
factors (HIFs), which adapt cellular functions to low oxygen 
concentration conditions.21 Further investigation of the role(s) of 
increased NQO1 expression in carcinogenic induction and 
progression are currently under investigation, and NQO1 is a 
promising target for the development of anticancer therapies based 
on bioactivatable prodrug quinones. In this context, McCarley et al. 
have investigated the use of the trimethyl lock quinone systems for 
the interrogation of enzymatic processes involving NQO1 and 
delivered important contributions to the field.22-25 
 
Trimethyl lock quinones have been used to construct activatable 
reporter molecules for selective and sensitive detection of NQO1 
activity. One of the first examples was a rhodamine-morpholino 
urea derivative, which was conjugated to a trimethyl lock quinone 
in order to generate activatable fluorescence emission.26 The probe 
was readily prepared by coupling a trimethyl lock quinone to a 
rhodamine derivative in the presence of 1-ethyl-3-(3-
dimethylaminopropyl)carbodiimide (EDC) using a mixture of 
DMF/pyridine as the solvent. Nothwithstanding the ease of the 
synthesis, only a moderate 34% yield was attained. The activation 
mechanism relied on the reduction of the quinoidal moiety by 
NQO1 to afford the hydroquinone analogue, which underwent 
lactonization to release the fluorescent rhodamine derivative 
(Figure 2B). Compound 4 exhibited poor fluorescence with a 
quantum yield lower than 1%, whereas the final released molecule 
6 displayed around 100-fold increase and bright fluorescence 
emission (e.g. quantum yields around 50%). 
 
Optimal trimethyl lock quinone-based probes should display (a) 
rapid cell uptake, (b) selective enzymatic activation, (c) low 
fluorescence quantum yields for the unactivated probes and high 
fluorescence emission upon release of the reporter, (d) good 
retention of the reporter inside the target cells and (e) significant 
differences in energies of absorption maxima (λabs. probe vs λabs. 
reporter) and emission maxima (λem. probe vs λem. reporter) to 
maximize signal-to-background ratios.25 Figure 2C features several 
probes which release fluorescent reporters upon specific stimuli 
and display the properties listed above, being suitable candidates 
for direct imaging of enzymatic biological processes. The 
naphthalimide derivative 7 was designed for the detection and 
visualization of intracellular enzymatic processes involving NQO1 
with high sensitivity and minimal cytotoxicity, even at higher 
concentrations than those used for biological experiments. The 
enzymatic reduction of the quinoidal system -which quenched the 
naphthalimide core by PeT in the intact probe- released bright 
green fluorescence emission, enabling the detection of NQO1 in 
cancer cells.22 
 
Despite rather basic chemistry is mostly sufficient for the 
preparation of the probes in this research area, the intrinsic 
complexity of biological systems poses challenges to the 
identification of good reporter-quinone pairs. In addition to 
naphthalimides, the rhodamine scaffold has been also successfully 
used for NQO1 detection. The bright fluorescence emission of 
rhodamine -with fluorescence quantum yields over 80%- enabled 
the acquisition of microscope images of NQO1-expressing tumor-
derived colorectal and ovarian cancer cells with unprecedented 
signal-to-background ratios.22-25 
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Figure 2. (A) General overview of enzymatic prossesses involving trimethyl lock quinones. (B) Schematic representation of the release of 
fluorescent reporters after reaction with NQO1. (C) Chemical probes including different fluorophores with diverse spectral properties. 
 
Imaging agents emitting fluorescence in the near-infrared region 
(i.e., 650-900 nm) enable deeper tissue penetration with low 
phototoxicity and higher signal-to-background ratios due to 
minimal tissue autofluorescence, which are necessary for in vivo 
imaging studies.27,28 In this context, near-infrared probes including 
trimethyl lock quinones have been reported by the groups of 
McCarley, Zhang and Yi (Figure 3).29,30 These compounds have 
remarkable translational potential for the visualization of solid 
tumors and the determination of tissue resection borders during 
intraoperative imaging in cancer surgery. The probes were prepared 
through synthetic routes coupling trimethyl lock quinones and 
selected near-infrared reporters so that the latter would be 
released into the media upon enzymatic recognition. Initially, the 
heterocyclic reporter tricarbocyanine 16 was prepared in two steps 
from 1-ethyl-2,3,3-trimethyl-3H-indol-1-ium iodide. Subsequently, 
the trimethyl lock derivative 15 was chlorinated and then linked to 
the cyanine unit via a N-alkylation (Figure 3A).29 Notable features of 
the resulting probes were their near-infrared emission wavelengths, 
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long Stokes shifts, and reasonable photostability. The electron-
deficient nature of the trimethyl lock quinone was important to 
exert effective PeT quenching on the tricarbocyanine scaffold and 
to maintain the reporter unit intact before its reaction with the 
NQO1 enzyme. Notably, very large differences in the spectral 
properties before and after enzymatic reaction were observed (e.g. 
λabs. (16): 606 nm vs λabs. (17): 786 nm; λem. (16): 755 nm vs λem. (17): 
798 nm). Furthermore, the release of the fluorophore upon 
interaction with the enzyme resulted in a 14-fold increase in the 
fluorescence quantum yields. The low background fluorescence of 
the fluorogenic precursor together with the significant ‘turn-on’ 
effect resulted critical to obtain high signal-to-background ratios in 
cell imaging studies. Bioimaging assays were performed in 
colorectal carcinoma cell lines (HT-29) and ovarian cancer cell lines 
(OVCAR-3 and SHIN3), which express high levels of the enzyme 
NQO1. H596 non-small lung carcinoma cells were used as negative 
controls expressing low levels of NQO1. Microscope cell images 
confirmed brighter fluorescence emission in HT-29 (NQO1+), 
OVCAR-3 (NQO1+), SHIN3 (NQO1+) whereas H596 cells (NQO1-) 
presented very low fluorescence intensity. Compound 17 was 
recently used for in vivo imaging of ovarian cancer in a mouse 
model upon activation by hNQO1, enabling the identification of 
cancerous lesions with minimal interference from tissue 
autofluorescence.31 
In the context of near-infrared fluorophores, Zhang and Yi recently 
described two novel probes (23 and 24, Figure 3B) for the detection 
of NQO1 activity in vitro and in mice. These near-infrared ‘turn-on’ 
probes relied on activation by intramolecular charge transfer (ICT) 
and PeT mechanisms using merocyanine and tricarbocyanine 
structures.30 The synthesis was accomplished in a single step and 
designed to release the near-infrared reporters after enzymatic 
reduction (Figure 3B). Compound 24 showed a 33-fold fluorescence 
enhancement after NQO1 treatment and marginal cytotoxicity, 
being further applicable to in vitro imaging of human colorectal and 
breast cancer cells as well as in vivo whole-body imaging in mouse 
models.  
 
In the last decade, in vivo imaging studies have been revolutionised 
by the emergence of two-photon fluorescence microscopy, which 
allows deep imaging of biological specimens with low phototoxicity. 
Recently, the groups of Cui, Kim and Yoon have described a two-
photon fluorescent probe for NAD(P)H:quinone oxidoreductase 
detection in which an aminoacetyl-naphthalene derivative was 
conjugated to a trimethyl lock quinone.32 In this case, the 
interaction of the probe with hNQO1 led to the release of a two-
photon compatible reporter with an emission wavelength around 
540 nm, as demostrated in assays for the detection of NQO1 in 
living cells. The authors also corroborated the specificity in cells 
expressing high and low levels of NQO1. Specifically, HT29 
colorectal cancer cells displayed a strong fluorescence ‘turn-on’ 
effect, whereas NQO1-negative breast cancer cell lines (i.e., MDA-
MB-231 and MDA-MB-468) showed negligible fluorescence 
response (Figure 4A). 
In addition to the visualization of disease biomarkers, fluorescent 
probes can also be used for real-time quantitative monitoring of 
drug localisation (e.g. anticancer therapy) in targeted cells. Some 
anticancer drugs do contain inherent chromophore groups that 
enable direct fluorescence imaging in cells, and their conjugation to 
trimethyl lock quinones has been used to generate prodrugs and 
monitor NQO1-dependent release in cells. Zeng and Wu groups 
reported a NQO1-activatable theranostic prodrug (28) containing 
the anticancer drug camptothecin, which is an inhibitor of the 
enzyme topoisomerase I (Figure 4B).33 In this case,  the emission of 
compound 28 was quenched by PeT, and fluorescence was only 
observed when the prodrug was cleaved and camptothecin was 
released to the intracellular space. Cell viability assays indicated 
that camptothecin on its own was not able to exert enough 
cytotoxicity, highlighting the crucial role of the quinone propionic 
acid moiety. This chemical strategy opens multiple avenues for the 
use of NQO1-activatable theranostic prodrugs to generate enzyme-
dependent antitumor drugs that effectively target cancer cells 
overexpressing NQO1 with reduced side effects and toxicity in other 
cell types. 
 
Shin et al.34 developed an efficient chemical strategy for enzyme-
triggered targeted therapy (Figure 4C) by making use of trimethyl 
lock quinone prodrugs. In addition to the NQO1-activatable 
component, the prodrugs included a biotin molecule as a cancer-
targeting unit to enhance the selective uptake of the prodrug in 
cancer cells expressing a biotin receptor in their surface. Once 
internalised, the trimethyl lock system was activated by NQO1 to 
release the cytotoxic drug camptothecin only in target cancer cells. 
The synthesis of these complex architectures was achieved in 9 
steps, including a copper-catalyzed alkyne-azide cycloaddition to 
form a triazole bond between the ligand (i.e., biotin) and the drug 
(i.e., camptothecin). Finally, the trimethyl lock quinone was 
incorporated via an aromatic linker to assemble these sophisticated 
theranostic quinone-based prodrugs.  
 
The latest addition from McCarley et al. in trimethyl lock based 
turn-on probes for the detection of NQO1 in cancer cells involved a 
rhodamine fluorophore (λem.: 520 nm) that was activated via 
hydrolysis of the spyrocicle moiety. The compound displayed 200-
fold fluorescence increase after interaction with the enzyme target, 
which facilitated fluorescence microscopy experiments of colorectal 
and ovarian cancer cell lines with excellent signal-to-background 
ratios.35 
Despite the fast-growing development in this area of research, the 
generation of probes based on the trimethyl lock system is still 
incipient and often requires multidisciplinary approaches in 
chemical biology. In particular, the discovery of probes that release 
stable and efficient near-infrared reporters for in vivo imaging 
remains challenging. The challenges of developing activatable near-
infrared probes which can be obtained through simple synthetic 
methods and possess optimal spectral properties are reflected in 
the paucity of reported examples in the literature. 
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Figure 3. Trimethyl lock quinone fluorescent probes. (A) Mechanism of activation for NQO1-sensitive tricarbocyanine probes and their use 
in confocal and differential interference contrast images of H596 (negative), OVCAR-3 (positive), HT-29 (positive), and SHIN3 (positive) 
cells. Fluorescence images were obtained using 633 nm excitation and collecting fluorescence emission in the 660−820 nm range. Scale bar: 
20 μm. (B) Microscopy images of NQO1-positive MB231-1640 cells (A and C) and HT29 cells (B and D) in the absence (A and B) or in the 
presence (C and D) of the inhibitor dicoumarol together with probe 24. Cancer cell detection limit and sensitivity of the probe (24) in living 
mice. Fluorescence images of mice after injection of 107, 105, 103 and no HT29 cells at different time points. Mice were also pre-treated 
with dicoumarol, in the case where they were administered 107 HT29 cells. Images reproduced with permission from American Chemical 
Society (ref. 29) and Elsevier (ref. 30). 
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Figure 4. Synthesis of the trimethyl lock imaging and theranostic probes targeting NQO1 and respective characterisation studies. (1) Two-
photon microscope images of NQO1-positive HeLa cells (a and c), fluorescence spectrum (b), and time-course fluorescence (d) after 
incubation with the probe 25 (1 µM) for 30 min. (2) Fluorescence images of A549 cells in the absence (control) or in the presence of the 
prodrug 28 (10 µM) at different incubation times. For the inhibition experiments, A549 cells were pre-treated with dicoumarol (20 µM), 
then the prodrug 28 (10 µM) was added and incubated for another 2 h. (3) Subcellular localisation of compound 32. Fluorescence co-
localisation studies with Mito-tracker Red FM and ER-tracker Red in A549 cells, where HeLa cells were treated with the prodrug 35 (10 μM) 
for 24 h. Images reproduced with permission from Royal Society of Chemistry (ref. 32 and 33) and American Chemical Society (ref. 34). 
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4. Turning non-fluorescent quinone scaffolds into 
fluorescent therapeutic probes 
Nature is an endless source of inspiration for chemists due to the 
broad complex array of chemical structures found in natural 
products. Natural products have been used in therapy since ancient 
times, and are still currently an important chemical resource in the 
development of drugs for numerous diseases. Lapachones (Figure 
5A) and their derivatives are quinone-based natural substrates 
widely used as therapeutics for different applications.36-38 Because 
these quinones are typically non-fluorescent and therefore 
unsuitable for direct visualization of therapeutic targets and/or 
interrogation of mechanisms of action or gene expression,39 a 
number of approaches have been pursued to incorporate 
appropriate chemical modifications to quinoidal structures. The  
straightforward generation of fluorescent heterocycles such as 
phenazines, oxazoles and imidazoles from lapachone-type quinoidal 
derivatives has emerged as an important strategy to produce new 
disease biomarkers.  
 
Brinn et al. have used β-lapachones as the starting materials in the 
synthesis of symmetric phenazines (Figure 5A).36 This fluorescent 
nitrogen-containing heterocycle was prepared in a single step by 
reacting the lapachone precursor with an ammonia source. 
Advantageously, compound 36 displayed bright fluorescence with 
quantum yields around 40%, being optimal fluorophores for 
bioimaging. Similarly, Pinto et al. have reported the synthesis of 
complex fluorescent diazaazulenones37 from the reaction of 
lapachones with ammonium acetate in acidic conditions. More 
recently, our group has reported cyclometallated ruthenium 
complexes from naturally-occurring lapachones. The investigation 
of their photophysical properties revealed emission maxima in the 
red region of the visible spectra (λem.: 620 nm), being promising 
candidates for subsequent applications in fluorescence imaging.38 In 
these examples, the common synthetic approach is based on the 
modification of the redox centre of the lapachone core to prepare 
fluorescent heterocycles. Alternatively, aldehyde-containing dyes 
can be also synthesized from non-fluorescent lapachones. Some of 
these compounds possess multiple emission bands, which is a 
remarkable feature for the preparation of fluorescent ratiometric 
probes or the design of fluorescent dye cocktails.40 As shown in 
Figure 5B, a number of derivatives displayed fluorescence emission 
in the blue (e.g. between 420 and 450 nm) and green (e.g. between 
510 nm and 560 nm) regions of the visible spectra. Fluorescence 
microscope images of both live and fixed cells upon incubation with 
compounds 39 and 40 showed intracellular patterns resembling 
mitochondrial staining, with preferential accumulation in areas 
around the nucleus and slight diffusion throughout the cytoplasm.41 
Co-localisation experiments with the commercially available dye 
Mitotracker corroborated the fluorescence localisation of 
compounds 39 and 40 in the mitochondria of human MCF7 breast 
cancer cells. This work represents the first chemical synthesis of 
lapachone-derived imidazoles and their bioimaging application as 
selective fluorescent markers of mitochondria in live cells. 
 
Another important example of lapachone-derivatisation using the 
same redox centre modification strategy has resulted in the 
preparation of fluorescent naphthoxazoles and their boron 
derivatives. These compounds are useful markers to monitor 
endocytic pathways in live PC3 cancer cells by fluorescence 
microscopy.42 Furthermore, comparative assays with acridine 
orange suggest that these new fluorophores present better 
selectivity for the internalisation of endocytic processes. The boron-
containing analogues showed enhanced spectral properties as 
efficient π-conjugated systems, including large Stokes shifts (i.e., 
around 70 nm) and high fluorescence quantum yields. Compounds 
41 and 42 were capable of selectively staining different organelle 
structures in the canonical endocytic pathway (i.e., early 
endosomes, late endosomes and lysosomes) without causing cell 
toxicity. These probes enabled dynamic studies of the endocytic 
trafficking in live cells and direct visualisation of endocytosis 
through caveolar vesicles and the canonical pathway. As a result, 
the simple and efficient synthesis of these nature-inspired 
lapachone derivatives represents a valuable chemical strategy to 
produce new tools to study complex cellular uptake processes by 
means of fluorescence imaging.  
 
Other examples have been described towards chemical probes 
targeting specific intracellular microenvironments. For instance, 
oxazole-based compounds have been designed to target lipophilic 
environments.43 Initially, long hydrophobic alkyl chains were 
conjugated to the furan ring through triazole linkers, but the 
resulting products showed low efficacy for staining intracellular lipid 
structures. On the other hand, phenyl-substituted oxazoles 
(compounds 43 and 44) showed significant accumulation in lipid 
droplets. In order to confirm their intracellular localisation, 
compound 44 was compared to lipid-staining BODIPY dyes to 
analyse their intracellular staining patterns. The oxazole-lapachone 
displayed little photobleaching or degradation, indicating high 
chemical stability and photostability inside cells. These oxazole 
derivatives constitute an interesting family of fluorophores because 
of their high molar extinction coefficients and their ability to 
undergo ESIPT (excited-state intramolecular proton transfer), which 
often results in extraordinarily long Stokes shifts (i.e, over 140 nm). 
  
The C-ring modification of lapachones has been also exploited for 
the preparation of theranostic fluorescent probes. For instance, a 
lapachone-based BODIPY hybrid (45) was recently reported as a 
novel theranostic construct with green fluorescence emission and 
potent antitumor activity.44 Confocal microscopy studies revealed 
the ability of this hybrid compound to stain mitochondria. 
Furthermore, studies to elucidate the cytotoxic activity and the 
mechanism of action of this hybrid were described. This adduct 
represents the first example of a fluorescent quinoidal system with 
both capabilities as a fluorophore and as a potent antitumor drug. 
Importantly, this report demonstrates that the intrinsic lack of 
fluorescence of the quinoidal structure can be overcome by 
conjugation to appropriately bright fluorescent scaffolds to 
generate highly fluorescent derivatives with therapeutic activity.  
 
In summary, these examples prove the adaptability of lapachones 
to different chemical approaches introducing modifications at 
either the redox centre and/or the C-ring to generate fluorescent 
derivatives for imaging assays. The versatility of these approaches 
allows for the extension of π-conjugated planar systems, thus 
opening multiple avenues for the design of fluorophores with 
bespoke photophysical properties for different bioimaging studies. 
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(B) Redox Centre modification for preparing fluorescent compounds:
(A) Examples of fluorescent heterocycles prepared by redox centre modification of lapachones:
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Figure 5. Fluorescent probes obtained from the C-ring modification of lapachones. (1) Fluorescence microscope images of MCF-7 cells 
incubated with compound 40 and Mitotracker. Image A shows the staining profile of compound 40 and image C shows the staining profile 
of Mitotracker. The white arrows indicate the perinuclear staining accumulation for all markers used. Image B displays the overlay of both 
green and red fluorescence channels, showing co-localisation in yellow. Cell nuclei are identified in the brightfield image D with the letter 
N. Scale bar: 25 μm. (2) Fluorescence microscope images of live PC3 cancer cells upon staining with compound 41 (blue). As a positive 
control, cells were stained with acridine orange (green). Compound 41 was localised within subcellular organelles corresponding to the 
endocytic pathway. Red arrows point at the staining of lysosomes, and white arrows point at the nucleus stained with acridine orange 
(non-specific staining). Scale bar: 20 μm. (3) Fixed Caco-2 cells stained with compound 44 and a commercial available BODIPY dye. (A) Cells 
stained with compound 44 showing its accumulation in the lipid droplets (yellow arrowheads) and in some areas of the cytoplasm. (B) Lipid 
droplets are also stained with BODIPY dyes. (C) and (D) correspond to the brightfield images. N: nucleus, scale bar: 25 µm. Images 
reproduced with permission from Wiley-VCH (ref. 41) and Royal Society of Chemistry (ref. 42 and 43). 
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5. Switchable quinone/hydroquinone pairs for 
bioimaging applications 
Fluorophores endowed with quinone/hydroquinone (Q/HQ) pairs 
constitute another remarkable family of quinone-based molecules. 
These compounds are prototypical redox species with important 
roles in cells, particularly in electron transfer and energy 
conservation systems. In general, probes with Q/HQ pairs work by 
means of PeT activation/deactivation between a quinoid redox 
center (PeT acceptor) and a fluorescent reporter (PeT donor), which 
modulates the fluorescence emission. Different reporters have 
been employed so far, including BODIPY and cyanines among 
others, yielding probes for the imaging of redox processes with high 
sensitivity. The groups of Cosa and Jiang have described interesting 
examples of quinoidal systems based on the BODIPY scaffold (Figure 
6A).45-46 While Cosa et al. synthesized a para-quinone containing 
BODIPY (45), Jiang et al. prepared an ortho-quinone coupled to aza-
BODIPY (47). In both cases, the reduction of the quinoidal moiety, 
generating HQs (46) and (48) led to a significant increase in 
fluorescence. Additional examples using quinones found in natural 
metabolites have been also reported. An activatable fluorescent 
analogue of vitamin K was synthesized via coupling of a BODIPY 
core to menadione to render a fluorogenic probe showing 70-fold 
fluorescence increase upon reduction of the quinone moiety.47The 
probe functioned as an electron shuttle in the presence of a 
NAD(P)H:quinone oxidoreductase, either NADP or NADPH and 
cytochrome C. Other protein complexes, such as intracellular 
complex I, can be also detected by monitoring the redox state with 
Q/HQ pairs. Long et al. described the synthesis and application of 
bioconjugates containing Q/HQ pairs attached to QDs for the 
monitoring of complex I levels in human neuroblastoma SH-SY5Y 
cells.48 Therein, the authors also demonstrated the potential use of 
these compounds for early-stage diagnosis of Parkinson disease, 
thus highlighting the potential of these nanosensors for future 
clinical applications. 
 
(B) Ubiquinone-CdSe/ZnS QDs as redox fluorescence biosensor:
(A) General scheme involving the Qs/HQs pair and examples of Qs/HQs-based boron-dipyrromethene redox probes:
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Figure 6. (A) General representation of the Q/HQ pairs and examples of BODIPY-based redox probes. (B) Preparation of ubiquinone-
CdSe/ZnS QDs used as fluorescent redox nanoprobes. Fluorescence microscopy images showing the intracellular complex I level using 
Q2NS-QDs. Brightfield and fluorescent images were collected from human neuroblastoma SH-SY5Y cells with Q2NS-functionalised QDs. The 
expression levels of complex I increased in human SH-SY5Y cells after 24 h or upon exposure to rotenone at 100 nM (Damage I), 500 nM 
(Damage II) or 1 µM (Damage III). Images reproduced with permission from Springer Nature (ref. 48). 
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Recently, Chao et al. have described Ir(III)-anthraquinone 
complexes as two-photon probes (Figure 7A). The authors 
demonstrated the ability of compounds 54-57 to act as 
mitochondrial markers.49The phosphorescence of Ir(III) complexes 
was quenched by the quinoidal moiety, and restored under hypoxic 
conditions after a two-electron bioreduction process. The probes 
were activated by reductases in the presence of NADPH, which 
triggered the conversion of the anthraquinone moiety into the 
hydroquinone, rendering 26-fold increase in emission. These 
complexes also enabled imaging mitochondrial morphological 
changes in hypoxic environments. Since conventional mitochondrial 
imaging agents (e.g. MitoTracker dyes) show poor efficacy under 
hypoxic conditions, these molecules are a significant addition to the 
field. In solid tumors, several key processes take place under stress 
conditions involving low levels of nutrients and oxygen, including 
diffusion-limited hypoxia. 
Therefore, the use of efficient 'turn-off'/'turn-on' compounds such 
as Q/HQ pairs represents an attractive and elegant strategy to 
develop probes for imaging intracellular events in live cells. Han et 
al. described a quinone-based cyanine derivative as an on-off-on 
fluorescent probe for monitoring oxidative stress and subsequent 
repair in live cells.50 In this example, the authors took advantage of 
the variations in fluorescence intensity of the cyanine (58) in 
oxidative and reductive environments. Compound 58 showed a 
fluorescence decrease and a color change from blue to purple in the 
presence of H2O2, then the fluorescence was gradually restored to 
upon reaction of quinone 59 with GSH via Michael addition (Figure 
7B). 
 
(A) Ir(III) anthraquinone complexes as probes for mitochondria imaging:
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Figure 7. (A) Fluorescence microscopy images of A549 cells incubated with compounds 54-57 (5 µM) under hypoxic (1% O2) conditions for 
30 min at 37 C, followed by addition of 50 nM Mitotracker Green. Column a: brightfield images; column b: cells stained with Mitotracker 
Green; column c: OPM confocal phosphorescence images; column d: TPM confocal phosphorescence images; column e: overlay images of 
columns a-d; scale bars: 10 µm. (B) Fluorescence microscopy images of HL-7702 cells under H2O2 oxidative stress/thiol-induced repair: a) 
HL-7702 cells loaded with 5 µM 58 for 3 min; b) 58-loaded cells treated with 25 µM H2O2 for 9 min; c) cells treated as described in (b) after 
culture for 3 h; d) cells incubated for 30 min with N-ethylmaleimide (100 µM), then for 3 min with 58 (5 µM); e) cells described in (d) after 
exposure to H2O2 (25 µM); f) cells treated as described in (e) after additional culture for 3 h. Images reproduced with permission from 
Wiley-VCH (ref. 49) and Royal Society of Chemistry (ref. 50). 
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5. Conclusions  
The versatility of biological functions exhibited by the quinoidal 
compounds is well-documented and makes them privileged 
chemical structures for a wide variety of disorders, including cancer, 
malaria and leishmaniasis, among others. The main mechanisms by 
which quinones exert their action in cells involve the stimulation of 
oxidative stress and/or the alkylation of specific biomolecules. As a 
result, there has been growing interest in designing chemical 
strategies to synthesize novel quinone derivatives and to evaluate 
their properties in different biological systems. Quinones constitute 
a relatively simple chemical structure, and yet the development of 
new synthetic strategies presents remarkable challenges. The ability 
of quinones to participate in bioreduction and biooxidation 
processes enables their use for numerous applications in different 
fields, from cell biology to energy storage. Furthermore, the 
multiple features of quinones make them a ‘Swiss Army knife’-like 
chemical scaffold for the discovery of new materials, therapeutic 
agents and analytical probes. In this review, we covered the 
emerging rise of quinone-based fluorophores for imaging biological 
processes in multiple environments, from cells to in vivo animal 
models. Recent work describing the synthesis of fluorescent probes 
from naturally occurring quinones (e.g. lapachones) as well as their 
application to stain subcellular organelles or to monitor specific 
intracellular environments (e.g. hypoxia) exemplify the value of 
these novel fluorescent molecules. Over the years, the importance 
of the quinoidal framework in the preparation of chemical agents 
for medicinal purposes has been indisputable. Chemists are now 
facing the challenge of exploiting quinones to construct 
sophisticated structures (e.g. activatable fluorescent probes) that 
can bring new properties to this interesting family of chemical 
structures. 
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